Amplifying Patient Voice: Success Story March 27, 2026 Showcasing Outstanding Patient Partnership in the HYPERION CCA Study We are delighted to spotlight the partnership between HYPERION CCA research team, and the Cholangiocarcinoma Foundation (CCF). The HYPERION CCA study is led by Dr. Eugene Koay at The University of Texas MD Anderson Cancer Center, one of our grantees. This research team […]
Amplifying Patient Voice: Success Story Read More »
Grantee Spotlight: Developing New Immune-Based Treatments for Aggressive Brain Cancer March 24, 2026 The Challenge Malignant brain tumors, such as glioblastoma, are among the most aggressive cancers in adults. Despite maximal standard therapy – surgery followed by radiotherapy and temozolomide chemotherapy – most patients live only about 15 to 16 months after diagnosis. For decades, progress has been slow, and new treatment approaches are
Grantee Spotlight: Developing New ImmuneBased Treatments for Aggressive Brain Cancer Read More »
